1. Home
  2. TPC vs MIRM Comparison

TPC vs MIRM Comparison

Compare TPC & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tutor Perini Corporation

TPC

Tutor Perini Corporation

HOLD

Current Price

$68.30

Market Cap

3.1B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$72.69

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPC
MIRM
Founded
1894
2018
Country
United States
United States
Employees
N/A
N/A
Industry
General Bldg Contractors - Nonresidential Bldgs
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TPC
MIRM
Price
$68.30
$72.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$82.00
$82.82
AVG Volume (30 Days)
540.3K
593.2K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
0.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,103,323,000.00
$471,794,000.00
Revenue This Year
$24.11
$53.14
Revenue Next Year
$11.90
$19.83
P/E Ratio
N/A
N/A
Revenue Growth
19.22
53.66
52 Week Low
$18.34
$36.88
52 Week High
$77.00
$78.55

Technical Indicators

Market Signals
Indicator
TPC
MIRM
Relative Strength Index (RSI) 62.14 55.55
Support Level $58.11 $71.04
Resistance Level $63.60 $73.50
Average True Range (ATR) 2.62 2.74
MACD 0.70 0.33
Stochastic Oscillator 98.02 78.35

Price Performance

Historical Comparison
TPC
MIRM

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: